Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for SHPM.Y from our risk checks.
Shanghai Pharmaceuticals Holding Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥7.69 |
52 Week High | CN¥10.47 |
52 Week Low | CN¥6.54 |
Beta | 0.25 |
1 Month Change | -5.76% |
3 Month Change | 4.91% |
1 Year Change | -19.31% |
3 Year Change | -21.45% |
5 Year Change | -31.83% |
Change since IPO | -38.68% |
Recent News & Updates
Recent updates
Shareholder Returns
SHPM.Y | US Healthcare | US Market | |
---|---|---|---|
7D | -1.3% | 0.2% | 1.3% |
1Y | -19.3% | 5.7% | 29.8% |
Return vs Industry: SHPM.Y underperformed the US Healthcare industry which returned 7.2% over the past year.
Return vs Market: SHPM.Y underperformed the US Market which returned 30.4% over the past year.
Price Volatility
SHPM.Y volatility | |
---|---|
SHPM.Y Average Weekly Movement | 8.3% |
Healthcare Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SHPM.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: SHPM.Y's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 47,811 | Bo Shen | https://www.sphchina.com |
Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system.
Shanghai Pharmaceuticals Holding Co., Ltd Fundamentals Summary
SHPM.Y fundamental statistics | |
---|---|
Market cap | US$7.97b |
Earnings (TTM) | US$637.92m |
Revenue (TTM) | US$35.35b |
13.8x
P/E Ratio0.2x
P/S RatioIs SHPM.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SHPM.Y income statement (TTM) | |
---|---|
Revenue | CN¥254.88b |
Cost of Revenue | CN¥223.22b |
Gross Profit | CN¥31.66b |
Other Expenses | CN¥27.06b |
Earnings | CN¥4.60b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Mar 28, 2024
Earnings per share (EPS) | 1.24 |
Gross Margin | 12.42% |
Net Profit Margin | 1.80% |
Debt/Equity Ratio | 64.5% |
How did SHPM.Y perform over the long term?
See historical performance and comparison